Transvenous leads continue to be the standard means to deliver bradyarrhythmia and tachyarrhythmia device therapy. Risk factors for cardiac implantable electronic devices (CIED) infection or complications of transvenous lead extraction (TLE) and mortality represent a complex interplay between non-modifiable patient-related factors and actionable implant-related characteristics or adverse events. Careful attention to patient screening, infection mitigation, lead selection, and implant technique may enhance safety of the index procedure and subsequent clinical management.
Keywords: Cardiac implantable electronic device; Implantable cardioverter defibrillator; Lead extraction; Lead implantation; Pacemaker.
Copyright © 2024 Elsevier Inc. All rights reserved.